Stayton’s eclectic research group works at the interface of molecular science and applied molecular bioengineering in the drug delivery, diagnostics, and regenerative medicine fields. Stayton has a strong interest in translating the group’s research, has been awarded several patents, and is a co-founder of the startup companies PhaseRx Inc. based on his group’s drug delivery work, and Nexgenia based on the lab’s diagnostic work.
Associate Director for Education206 543-4353 E-mail
Overney’s research interests lie in cognitive molecular engineering based on nanoscale fundamentals with focus on enhanced electronic, photonic, ionic, energy, momentum and mass transport properties, based on molecular relaxations and entropic cooperative properties in complex organic thin films. His group is known for its pioneering efforts in developing novel scanning probe methods towards mapping inter- and intra-molecular energetics and transitions in thin film and self-assembled systems.
“The Institute will be flexible and responsive – it will align its efforts with the most creative molecular engineering and sciences research wherever it is occuring.” Pat Stayton,Institute Director